Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NSAIDs and aspirin antiplatelet interaction study
NL-OMON27645Not yet recruiting
- Sponsor
- H.E. Vonkeman, M.D., Ph.D., rheumatologist, epidemiologist: is the performer of the trial
- Start
- Jan 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of aspirin, naproxen, ibuprofen, meloxicam and etoricoxib in cardiac morbidity (5 arms), sponsored by H.E. Vonkeman, M.D., Ph.D., rheumatologist, epidemiologist: is the performer of the trial. Primary endpoints: Primary comparison: naproxen interaction, Primary comparison: ibuprofen interaction and 2 more. Planned start Jan 2009; status: not yet recruiting.
02
Drugs
aspirinnaproxenibuprofenmeloxicametoricoxib
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on NL-OMON27645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27645.